Eukaryotic translation initiation factor 3H suppression inhibits osteocarcinoma cell growth and tumorigenesis

Eukaryotic translation initiation factor 3H subunit (EIF3H) is a member of the EIF3 family and exhibits a central role in translation initiation in higher eukaryotes. Although EIF3H expression is upregulated in numerous tumour types, its potential role in human osteosarcoma (OS) has not yet been inv...

Full description

Saved in:
Bibliographic Details
Published in:Experimental and therapeutic medicine 2018-06, Vol.15 (6), p.4925-4931
Main Authors: Hong, Song, Liu, Yi, Xiong, Huazhang, Cai, Dongfeng, Fan, Qinghong
Format: Article
Language:English
Subjects:
Apoptosis
Bone cancer
Cancer therapies
Cancer treatment
Care and treatment
Cell cycle
Cell growth
Chemotherapy
Gene expression
Genetic aspects
Health aspects
Infections
Investigations
Kinases
Osteosarcoma
Prostate
Protein synthesis
Proteins
Sarcoma
Translation (Genetics)
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Eukaryotic translation initiation factor 3H subunit (EIF3H) is a member of the EIF3 family and exhibits a central role in translation initiation in higher eukaryotes. Although EIF3H expression is upregulated in numerous tumour types, its potential role in human osteosarcoma (OS) has not yet been investigated. In the present study, it was demonstrated that mRNA expression was upregulated in the human OS cell lines Saos-2 and U2OS. A recombinant lentivirus harbouring short hairpin RNA targeting was constructed and successfully infected human OS Saos-2 and U2OS cells, resulting in 95% downregulated expression compared with the respective control groups. Knockdown of significantly inhibited the proliferation and colony formation of OS cells , and tumour growth in nude mice . Flow cytometry analysis revealed cell cycle arrest and promotion of apoptosis in OS cells with knocked down. In conclusion, the results strongly suggested that EIF3H is a critical factor mediating the growth of OS cells and may represent a novel therapeutic target.
ISSN:1792-0981
1792-1015
DOI:10.3892/etm.2018.6031